HCA Healthcare Inc. (HCA)
Health Care2 articles
Price chart
Why is HCA moving today?
-2.1%HCA is -2.1% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
HCA Healthcare Inc. (HCA) overview
HCA Healthcare is one of the largest U.S. hospital operators.
HCA is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
HCA Healthcare Inc. trades on the NYSE under the ticker symbol HCA. The most recent market data puts the share price at about $458.84. That is down 2.06% on the session. At that price the company is worth roughly $99.34B.
Over the past 52 weeks, HCA has traded between $353.99 and $556.52. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 15.4. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns. HCA also pays a dividend. It yields around 0.68% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch HCA
HCA is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each HCA story as it breaks, and tags it bullish, bearish or neutral.
What moves HCA
- Earnings. HCA reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from HCA.
- Sector news. Health Care stocks often move together, so a rival's news can move HCA too.
Market Mood
Latest HCA news

HCA (HCA) Stock Gains Momentum on Guidance Report
HCA Healthcare (HCA) has seen positive stock performance following updated guidance. The company projected earnings per share of $3.30-$3.50 for the upcoming quarter, indicating a potential 10% increase compared to previous estimates. This upward revision is significant amidst a competitive healthcare market. HCA's stock is poised to benefit from the anticipated growth, which could attract more investors given current trading volumes.
Read More: HCA (HCA) Stock Gains Momentum on Guidance Report
HCA (HCA) Q1 2026 Earnings Call Highlights Key Financials
During the Q1 2026 earnings call, HCA (HCA) reported revenue growth of 5% year-over-year, reaching $14.2 billion. The company also shared an adjusted EPS of $3.45, reflecting strong performance compared to analyst expectations. Additionally, operating income rose to $2.1 billion, compared to $2.0 billion in the same quarter last year. This positive financial performance may indicate robust demand for healthcare services and could positively influence HCA's stock price in the upcoming months.
Read More: HCA (HCA) Q1 2026 Earnings Call Highlights Key FinancialsMore Health Care stocks
Frequently asked questions
Is HCA Healthcare Inc. in the S&P 500?
Yes. HCA Healthcare Inc. trades as HCA and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is HCA in?
HCA sits in the Health Care sector of the S&P 500.
Where can I find the latest HCA news?
Right here. This page collects recent HCA news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is HCA Healthcare Inc.'s stock price?
HCA last traded at about $458.84. Prices move all through the session, so this is the latest quote rather than a live one.
What is HCA Healthcare Inc.'s market cap?
HCA is worth roughly $99.34B. Market cap is the share price times the number of shares outstanding.
What is HCA's P/E ratio?
HCA trades at a trailing P/E ratio of about 15.4. The ratio compares the share price with earnings per share over the past year.